Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
Status: | Recruiting |
---|---|
Conditions: | Gastrointestinal |
Therapuetic Areas: | Gastroenterology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/31/2019 |
Start Date: | April 4, 2017 |
End Date: | December 2020 |
Contact: | Guillermo Tearney, MD, PhD |
Email: | gtearney@partners.org |
Phone: | 617-724-2979 |
The goal of this research is to follow Barrett's Esophagus patients for 3 years using the
tethered capsule endomicroscopy device with distal scanning and a compact imaging system in a
multi-site clinical study.
tethered capsule endomicroscopy device with distal scanning and a compact imaging system in a
multi-site clinical study.
The progression of Barrett's Esophagus will be studied over time using tethered capsule
endomicroscopy imaging and will be performed at 5 different clinical centers in the US,
namely: Massachusetts General Hospital (MGH),(MA), Mayo Clinic Jacksonville (FL), Mayo Clinic
Rochester (MN), Columbia University Medical Center (NY), Kansas City VA Medical Center (MO).
MGH will be the coordinating center of this multicenter study. Dr G. Tearney will serve as
study Sponsor Investigator.
The purpose of this study is to determine the natural history of Barrett's Esophagus using
TCE in subjects diagnosed with Barrett's Esophagus and undergoing surveillance endoscopy.
endomicroscopy imaging and will be performed at 5 different clinical centers in the US,
namely: Massachusetts General Hospital (MGH),(MA), Mayo Clinic Jacksonville (FL), Mayo Clinic
Rochester (MN), Columbia University Medical Center (NY), Kansas City VA Medical Center (MO).
MGH will be the coordinating center of this multicenter study. Dr G. Tearney will serve as
study Sponsor Investigator.
The purpose of this study is to determine the natural history of Barrett's Esophagus using
TCE in subjects diagnosed with Barrett's Esophagus and undergoing surveillance endoscopy.
Inclusion Criteria:
- Subjects over the age of 18
- Subjects who are capable of giving informed consent
- Subjects with a diagnosis of BE without high grade dysplasia, intramucosal
adenocarcinoma or esophageal adenocarcinoma, confirmed by endoscopic biopsy,
- Subjects who had or will have a standard of care EGD within 15 months
- Subjects must have no solid food for at least 4 hours prior to the procedure, and only
clear liquids for 2 hours prior to the procedure
Exclusion Criteria:
- Subjects with prior endoscopic ablation or resection treatment of BE at enrollment
visit
- Subjects with esophageal fistula and/or esophageal strictures
- Subjects with the inability to swallow capsules
- Self reported pregnancy
We found this trial at
5
sites
630 W 168th St
New York, New York
New York, New York
212-305-2862
Phone: 212-305-1909
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Phone: 617-724-2979
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials